The impact of the COVID-19 pandemic on cancer diagnosis in the state of Paraiba
DOI:
https://doi.org/10.33448/rsd-v11i6.28551Keywords:
Neoplasm; COVID-19; Early cancer detection.Abstract
Objective: to analyze the impact of the COVID-19 pandemic on cancer diagnosis in the periods from 2019 to 2021. Methodology: this is a cross-sectional and descriptive study, data collection was carried out through the DATASUS TABNET application in the period 2019, pre-pandemic year and in the 2020-2021 biennium. Results: A reduction in the number of cases of cancer diagnoses was observed in the years 2020 and 2021 when compared to the year 2019. When staging, most diagnoses with filled fields occurred in stage III in all years analyzed. Regarding the primary site of the neoplasm, in the three years analyzed, the highest number of diagnoses was breast cancer, followed by non-melanoma skin cancer and cancer in connective tissue and other soft tissues in all years. Regarding the time between diagnosis and initiation of treatment, in the years 2019 and 2020 the majority occurred after 60 days of diagnosis. The year 2021 saw a decrease in the start of treatment for patients starting within 30 days of cancer diagnosis. Conclusion: A significant relationship was observed between the COVID 19 pandemic and the reduction of cancer diagnoses in Paraíba in the years 2020 and 2021.
References
Alves, F. A., Saunders, D., Sandhu, S., Xu, Y., de Mendonça, N. F., & Treister, N. S. (2020). Implicação do COVID-19 nas práticas de oncologia oral no Brasil, Canadá e Estados Unidos. Doenças Bucais.
Amorim, G. L. D. S., Assad, D. X., Ferrari, B. L., Rosa, D. D., Pereira, B. P., Clara, R. O., & Mathias, C. M. D. C. (2020). Oncologia da mama e a pandemia de COVID-19: recomendações da Sociedade Brasileira de Oncologia Clínica (SBOC). Revista Brasileira de Oncologia (Online), 16.
Andrew, T. W., Alrawi, M., & Lovat, P. (2021). Reduction in skin cancer diagnoses in the UK during the COVID‐19 pandemic. Clinical and experimental dermatology, 46(1), 145-146.
Bakouny, Z., Paciotti, M., Schmidt, A. L, Lipsitz, S. R, Choueiri, T. K, & Trinh, Q. D. (2021). Testes de rastreamento de câncer e diagnósticos de câncer durante a pandemia de COVID-19. JAMA oncology, 7 (3), 458-460.
Brasil. Ministério da Saúde (2021). Departamento de Informática do Sistema Único de Saúde (DATASUS) [online]. Brasília.
Carvalho, J. B., & Paes, N. A. (2019). Taxas de mortalidade por câncer corrigidas para os idosos dos estados do Nordeste brasileiro. Ciência & Saúde Coletiva, 24, 3857-3866.
Caldeira, A. L. G., de Souza, D. L. B., de Paula Bedaque, H., & Papa, T. D. Estudos Epidemiológicos–Conceitos Gerais. Descomplicando, 15.
Curtin, SC (2019). Tendências nas taxas de mortalidade por câncer e doenças cardíacas entre adultos de 45 a 64 anos: Estados Unidos, 1999-2017. Relatórios Nacionais de Estatísticas Vitais: Dos Centros de Controle e Prevenção de Doenças, Centro Nacional de Estatísticas de Saúde, Sistema Nacional de Estatísticas Vitais, 68 (5), 1-9.
Dinmohamed, A. G., Visser, O., Verhoeven, R. H., Louwman, M. W., van Nederveen, F. H., Willems, S. M., & Siesling, S. (2020). Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. The Lancet Oncology, 21(6), 750-751.
Ferrara, G., De Vincentiis, L., Ambrosini-Spaltro, A., Barbareschi, M., Bertolini, V., Contato, E., & Saragoni, L. (2021). Cancer diagnostic delay in northern and central Italy during the 2020 lockdown due to the coronavirus disease 2019 pandemic: assessment of the magnitude of the problem and proposals for corrective actions. American Journal of Clinical Pathology, 155(1), 64-68.
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4), 778-789.
Ministério da Saúde (2020). Instituto Nacional de Câncer (INCA). Nota técnica-DIDEPRE/CONPREV/INCA-30/3/2020. Detecção precoce de câncer durante a pandemia de COVID-19.
Oliveira, D. A. J. (2019). Políticas de saúde e diagnóstico precoce do câncer de mama no Brasil. Revista Enfermagem Digital Cuidado e Promoção da Saúde, 4, 1.
Oliveira, MMD, Malta, DC, Guauche, H., Moura, L. D, & Silva, G. A (2015). Estimativa de pessoas com diagnóstico de câncer no Brasil: dados da Pesquisa Nacional de Saúde, 2013. Revista brasileira de epidemiologia, 18, 146-157.
Reis, F. P., Santos, M. E. G., dos Reis Sena, W., Santana, R., de Freitas, T. S., da Silveira, H. F., & Junior, H. L. R. (2016). Perfil epidemiológico das pacientes com câncer de mama atendidas em uma unidade de saúde em São Francisco do Conde, Ba. Revista de Ciências Médicas e Biológicas, 15(2), 144-150.
Ribeiro, C. M., Correa, F. D. M., & Migowski, A. (2022). Efeitos de curto prazo da pandemia de COVID-19 na realização de procedimentos de rastreamento, investigação diagnóstica e tratamento do câncer no Brasil: estudo descritivo, 2019-2020. Epidemiologia e Serviços de Saúde, 31.
Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: a cancer journal for clinicians, 68(1), 7-30.
Simoes e Silva, A. C., Oliveira, E. A., & Martelli Jr, H. (2020). Coronavirus disease pandemic is a real challenge for Brazil. Frontiers in Public Health, 8, 268.
De Vincentiis, L., Carr, R. A., Mariani, M. P., & Ferrara, G. (2021). Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology. Journal of Clinical Pathology, 74(3), 187-189.
World Health Organization. (2018). Noncommunicable diseases country profiles 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Guilherme Lima Costa; Thainar Machado de Araújo Nóbrega; Adriana Duarte Miranda Queiroz; Geysa Maria de Sá Moraes Leandro; France Anne Reinaldo Maia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.